NUCALA 100 MG PO LIOF SOL INJ CT FA VD TRANS
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1010703350016 -
GGREM
510618010059201 -
Código de barras
7896015530341
O que a fonte publica
- Detentor do registro
- GLAXOSMITHKLINE BRASIL LTDA
- Princípios ativos
- MEPOLIZUMABE
- Embalagem
- 100 MG PO LIOF SOL INJ CT FA VD TRANS
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Biológico
- Classe terapêutica
- R3M - ANTIASMÁTICOS INIBIDORES DA INTERLEUCINA
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "NUCALA 100 MG PO LIOF SOL INJ CT FA VD TRANS",
"holder": "GLAXOSMITHKLINE BRASIL LTDA",
"stripe": "Tarja Vermelha",
"barcodes": [
"7896015530341"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "510618010059201",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "33.247.743/0001-10",
"priceRegime": "Regulado",
"productName": "NUCALA",
"productType": "Biológico",
"hospitalOnly": false,
"presentation": "100 MG PO LIOF SOL INJ CT FA VD TRANS",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "6639.80",
"icms-12": "7545.23",
"icms-17": "7999.76",
"icms-18": "8097.32",
"icms-19": "8197.28",
"icms-20": "8299.75",
"icms-21": "8404.81",
"icms-22": "8512.56",
"icms-23": "8623.11",
"icms-17.5": "8048.24",
"icms-19.5": "8248.20",
"icms-20.5": "8351.95",
"icms-22.5": "8567.49",
"icms-12-alc": "6736.81",
"icms-17-alc": "7142.64",
"icms-18-alc": "7229.75",
"icms-19-alc": "7319.00",
"icms-20-alc": "7410.49",
"icms-21-alc": "7504.30",
"icms-22-alc": "7600.50",
"icms-23-alc": "7699.21",
"withoutTaxes": "5928.39",
"icms-17.5-alc": "7185.93",
"icms-19.5-alc": "7364.46",
"icms-20.5-alc": "7457.09",
"icms-22.5-alc": "7649.53"
},
"pisCofinsList": "Negativa",
"substanceText": "MEPOLIZUMABE",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "8907.06",
"icms-12": "10121.66",
"icms-17": "10731.39",
"icms-18": "10862.27",
"icms-19": "10996.36",
"icms-20": "11133.82",
"icms-21": "11274.75",
"icms-22": "11419.30",
"icms-23": "11567.60",
"icms-17.5": "10796.43",
"icms-19.5": "11064.67",
"icms-20.5": "11203.84",
"icms-22.5": "11492.98",
"icms-12-alc": "9313.24",
"icms-17-alc": "9874.28",
"icms-18-alc": "9994.71",
"icms-19-alc": "10118.09",
"icms-20-alc": "10244.57",
"icms-21-alc": "10374.25",
"icms-22-alc": "10507.25",
"icms-23-alc": "10643.71",
"withoutTaxes": "8195.65",
"icms-17.5-alc": "9934.13",
"icms-19.5-alc": "10180.93",
"icms-20.5-alc": "10308.99",
"icms-22.5-alc": "10575.03"
},
"invalidBarcodes": [],
"activeSubstances": [
"MEPOLIZUMABE"
],
"therapeuticClass": "R3M - ANTIASMÁTICOS INIBIDORES DA INTERLEUCINA",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1010703350016",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "R3M",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:510618010059201"